~~<i id='8A17A274A3'><strike id='8A17A274A3'><tt id='8A17A274A3'><pre id='8A17A274A3'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：hotspot 2025-10-01 02:17:38 Page View：753

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Elevance, SCAN deals highlight health insurer acquisition scrutiny
Next article： Moonlake's readout produced a cash windfall. Risks remain

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

A new drug could help frostbite victims avoid its ravages

JonCherry/GettyImagesTwodaysafterhisrighthandfroze,HartBeznerrealizedforthefirsttimethathemightlosei

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

The drug industry has found itself all alone in Washington

MollyFergusonforSTATIfyou’readrugcompanyexecutive,youprobablyfeellikeyougotuponthewrongsideofbed.OnT